None listed
Conditions
Brief summary
As Prolonged grief disorder (PGD) is known to persist without appropriate treatment, it is imperative to identify those at risk of PGD and to develop effective treatments. Treatments for PGD thus far are largely based on the cognitive behavioural model and there is a mounting research demonstrating its effectiveness; however, these CBT-based interventions have several components and little is known about which components are essential to alleviate PGD symptomatology (Jordan and Litz, 2014). There is a need to clarify which bereaved individuals are likely to benefit from which types of interventions. Furthermore, given that rumination, avoidance, and disengagement are key maintaining mechanisms of PGD, studying the effects of BA will provide a clearer understanding about the possible underlying maintaining mechanisms underlying post-loss psychopathology. Additionally, many CBT-based grief treatments have required long treatment protocols and while longer protocols of BA have demonstrated preliminary evidence of reducing PGD symptomatology, few studies have investigated whether the same benefits are possible with a briefer BA protocol. As such, the current study seeks to examine the feasibility of a 6-week intervention of BATD-R among two bereaved individuals with PGD and explore patterns of symptomatic and functional change based upon weekly measures to monitor symptoms and track the hypothesised mechanisms of change. It was hypothesised that: (a) BATD-R will result in pre-post decreases in post-loss psychopathology including PGD, Post-traumatic stress disorder (PTSD), and Major Depressive Disorder (MDD) symptomatology, and (b) activation will be the mechanism of change underlying reductions in rumination, disengagement, and avoidance. If the current 6-week intervention is effective in reducing PGD symptomatology, this may provide a platform for advancing the development and implementation of brief behavioural activation interventions for PGD.
Interventions
This study was approved by the Curtin University Human Research Ethics Committee (approval number: HR2017-0241). This study is also registered as a clinical trial with the Australian New Zealand Clinical Trials Registry (registration number: ACTRN12617000494336p). Research Design: In line with goals for feasibility testing of novel treatments, a case series design was employed with two participants to measure symptoms of PGD before, during, and after BATD-R. Participants completed a three-week baseline until stability was established before beginning the intervention. The participants completed an initial phone screening interview to determine eligibility based on the inclusion/exclusion criteria. Next, participants completed a pre-assessment at the Curtin University Psychology Clinic and then completed week one baseline measures. Week two and three baseline measures were completed remotely and participants received SMS reminders each week. Participants completed the PG-13, BADS-SF, and UGRS at all baseline points, at each weekly treatment session, and at 1-week post-treatment. All other self-report measures were completed at pre-baseline and at 1-week post-treatment. The treatment protocol and session checklists were based on the BATD revised treatment manual (BATD-R; Lejuez et al. 2011). The protocol was adapted to tailor the treatment rationale for the unique responses in pathological grief and to ensure key elements of the sessions were covered within 6 sessions rather than 10 sessions as outlined in in the BATD-R manual. The treatment comprised six 1.5 hour weekly sessions over six weeks. Although previous studies have shown that one hour BA sessions per week have been effective (e.g. Lejuez et al., 2011; Daughters et al., 2008; Eisma et al., 2015), 1.5 hour sessions were assessed as more feasible to allow time for rapport building, grief story-telling, and completion of weekly measures. The intervention details are outlined below: Session 1 Psychoeducation about grief, rationale for BATD-R, introduction of daily monitoring forms Session 2 Life areas, values, and activities, and daily monitoring Session 3 Activity selection and ranking and monitoring with activity planning Session 4 Monitoring with activity planning Session 5 Contracts and monitoring with activity planning Session 6 Concept review of key elements, feedback on progress and monitoring with activity planning The therapist was a master of clinical psychology student with two years of clinical experience. To assess the integrity of treatment delivery, an adapted version of the BATD-R Adherence Checklists (Lejuez et al., 2011) was completed by the primary researcher at the completion of each treatment session. An independent rater who was familiar with the BATD-R viewed a random sample of 20 percent of video-recorded sessions and rated session adherence. Rater assessment indicated100 percent agreement with the therapist ratings. The therapist also had weekly team meetings with the research team to monitor adherence and obtain feedback on upcoming participant sessions.
Sponsors
Study design
Eligibility
Inclusion criteria
For inclusion, potential participants must meet criteria for PGD specified by Prigerson and colleagues (2009), be 18 years or older, and able to read, write, and understand English. Additionally, participants concurrently taking psychotropic medication must be on a stable dosage for three or more months prior to beginning the study.
Exclusion criteria
Exclusion criteria are moderate to high risk of suicide (e.g., plan, timeframe, recent self-harm) or a crisis situation in the last 4 weeks (e.g. acute symptoms resulting in hospital admission), receiving concurrent psychotherapy focused on grief symptoms, a history of psychotic symptoms, or alcohol or substance abuse disorders.